Search
Embecta Corp
EMBCAdd to Watchlist
3.350USD
-0.010-0.30%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
198.75MMarket Cap
1.75P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Embecta Corp is 5.50, ranking 186 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 14.00, with a high of 25.00 and a low of 11.00.
Analyst Rating
Based on
4
analysts
Hold
Current Rating
10.000
Target Price
+197.62%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Embecta Corp
EMBC
4
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
31
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Embecta Corp's expected revenue for the next quarter?
Embecta Corp's expected revenue is 254.54M.
What is Embecta Corp's price target?
Analysts forecast that Embecta Corp's price target is USD 14.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 11.00.
How have Embecta CorpEMBC's recent earnings per share performed?
The market expectation was USD -0.07, while Embecta CorpEMBC's earnings per share (EPS) for the previous quarter was USD 0.75. EPS for the next quarter is expected at USD 0.27.
What is the analyst rating for Embecta Corp?
Based on the ratings of Embecta Corp's stock from 4 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.